Table 2 Comparison of extra-pulmonary symptoms in mild and severe M. pneumoniae pneumonia group
From: Molecular epidemiology of Mycoplasma pneumoniae pneumonia in children, Wuhan, 2020–2022
Diseases | Mild (N = 198) | Severe (N = 173) | P-value |
|---|---|---|---|
Gastrointestinal | 25(12.6%) | 51(29.2%) | 0.0001029 |
Vomiting | 17(8.6%) | 23(13.3%) | 0.1967 |
Diarrhea | 19(9.6%) | 25(14.5%) | 0.1999 |
Liver function damage | 2(1.0%) | 10(5.8%) | 0.02112 |
Dermatological | 6(3.0%) | 17(9.8%) | 0.01269 |
Rash | 6(3.0%) | 17(9.8%) | - |
Cardiovascular | 3(1.5%) | 11(6.4%) | 0.0146 |
Electrocardiographic Abnormality | 3(1.5%) | 7(4.0%) | 0.1332 |
Kawasaki disease | 0 | 3(1.7%) | - |
Pericardial effusion | 0 | 1(0.6%) | - |
Hematologic | 0 | 2(1.2%) | - |
Thrombosis | 0 | 2(1.2%) | - |
Neurological | 0 | 1(0.6%) | - |
Encephalitis | 0 | 1(0.6%) | - |